GLP-1s are basically appetite’s off-switch: suddenly you’re “full” after three bites. Congrats on the smaller meals and ...

The US Food and Drug Administration (FDA) has instructed all GLP-1 drug-makers to update their warning labels to include the risk of serious kidney injury that can result from dehydration. This comes ...

These will help you build a supportive foundation for the body.

GLP-1 receptor agonists like semaglutide and tirzepatide have redefined what’s possible in the treatment of obesity and metabolic syndrome. These medications have shown remarkable results in appetite ...

One of the biggest risk factors for prediabetes is weight gain. Over the past several decades, rates of obesity have risen ...

Phenomix's MyPhenome test continues to demonstrate predictive accuracy in identifying which patients are most likely to respond to GLP-1 therapies such as semaglutide. Studies presented at Obesity ...

Psoriasis and psoriatic arthritis (PsA) are chronic, immune-mediated inflammatory diseases associated with several shared common comorbidities, of which obesity is one of the most prevalent. A complex ...

GLP-1 drugs are a class of medication used to treat type 2 diabetes and obesity. While they are generally safe to use, they can cause side effects, such as nausea, vomiting, and diarrhea. Starting on ...

The discussion surrounding GLP-1 medications needs to change to one that emphasizes science-based research and compassion.

Oprah Winfrey has spoken openly about using GLP-1s to lose weight in the last few years ...

ATLANTA — Initially marketed as diabetes treatments, GLP-1 drugs are now surging in popularity as weight loss solutions. With more people turning to the medications, Georgia’s Poison Center is seeing ...